Literature DB >> 17876201

International recommendations for consumption of long-chain omega-3 fatty acids.

William S Harris1.   

Abstract

As an appreciation of the cardioprotective properties of the long-chain, fish-oil-derived omega-3 fatty acids (eicosapentaenoic and docosahexaenoic acids) has grown, so too have official dietary guidelines. Health organizations and government agencies are typically recommending intakes that either maintain the status quo (about 100-200 mg/day in most western countries) or are intended to actively reduce risk for cardiovascular disease. The latter are around usually 400-600 mg/day, an amount likely to stimulate commercial interests to fortify foods with omega-3 fatty acids. Fortification is perhaps the best long-term solution to the chronically-low intake of omega-3 fatty acids that plagues western cultures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876201     DOI: 10.2459/01.JCM.0000289274.64933.45

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  15 in total

Review 1.  Modulation of inflammation by nutritional interventions.

Authors:  Francesco Visioli; Andrea Poli; Doriane Richard; Rodolfo Paoletti
Journal:  Curr Atheroscler Rep       Date:  2008-12       Impact factor: 5.113

2.  Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans.

Authors:  William S Harris; James V Pottala; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  J Nutr       Date:  2012-05-23       Impact factor: 4.798

3.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

4.  The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.

Authors:  Olivia I Okereke; Charles F Reynolds; David Mischoulon; Grace Chang; Nancy R Cook; Trisha Copeland; Georgina Friedenberg; Julie E Buring; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-03-08       Impact factor: 2.226

5.  Fish oil in primary and secondary cardiovascular prevention.

Authors:  Surya M Artham; Carl J Lavie; Richard V Milani; Rishi G Anand; James H O'Keefe; Hector O Ventura
Journal:  Ochsner J       Date:  2008

6.  The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents.

Authors:  César M Mejía-Barradas; Blanca E Del-Río-Navarro; Aarón Domínguez-López; Rafael Campos-Rodríguez; María de-Los-Á Martínez-Godínez; Saúl Rojas-Hernández; Eleazar Lara-Padilla; Edgar Abarca-Rojano; Ángel Miliar-García
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

7.  Bioavailability and spatial distribution of fatty acids in the rat retina after dietary omega-3 supplementation.

Authors:  Elisa Vidal; Bokkyoo Jun; William C Gordon; Marie-Annick Maire; Lucy Martine; Stéphane Grégoire; Spiro Khoury; Stephanie Cabaret; Olivier Berdeaux; Niyazi Acar; Lionel Bretillon; Nicolas G Bazan
Journal:  J Lipid Res       Date:  2020-10-30       Impact factor: 5.922

Review 8.  The omega-3 index: from biomarker to risk marker to risk factor.

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

9.  Why and How Meet n-3 PUFA Dietary Recommendations?

Authors:  Olivier Molendi-Coste; Vanessa Legry; Isabelle A Leclercq
Journal:  Gastroenterol Res Pract       Date:  2010-12-08       Impact factor: 2.260

10.  Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation.

Authors:  Stephan Winnik; Christine Lohmann; Eva K Richter; Nicola Schäfer; Wen-Liang Song; Florian Leiber; Pavani Mocharla; Janin Hofmann; Roland Klingenberg; Jan Borén; Burkhard Becher; Garret A Fitzgerald; Thomas F Lüscher; Christian M Matter; Jürg H Beer
Journal:  Eur Heart J       Date:  2011-01-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.